Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...

Devastating funding cuts from international donors are hitting countries hardest affected by HIV — but many are showing ...

Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...

Global Fund notes that the US has contributed more than $26.31 billion to date and pledged up to $6 billion for the Seventh ...

DAR ES SALAAM: TANZANIA National Coordinating Mechanism (TNCM) has reaffirmed its commitment to ensure the Global Fund ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

Canada, he says, should double its funding to the Global Fund — the international organization that distributes funds ...

Devastating funding cuts from international donors are hitting countries hardest affected by HIV -- but many are showing remarkable resilience and determination to keep progress alive.

Trump stopped the global fight against HIV/AIDS in its tracks. ... In 2022, Canada increased Global Fund contributions by 30 per cent, pledged $1.21 billion for 2023 to 2025.